Table III.
HNF-4α expression | |||||
---|---|---|---|---|---|
Characteristics | – | + | ++ | +++ | P-value |
n | 2 | 15 | 48 | 61 | |
Age (years) | 0.682 | ||||
<56 | 0 | 8 | 23 | 32 | |
≥56 | 2 | 7 | 25 | 29 | |
Gender | 0.563 | ||||
Male | 1 | 6 | 26 | 27 | |
Female | 1 | 9 | 22 | 34 | |
Differentiation | 0.499 | ||||
Well | 1 | 5 | 15 | 18 | |
Moderate | 1 | 3 | 20 | 21 | |
Poor | 0 | 7 | 13 | 22 | |
Tumor stage | 0.015 | ||||
T1 | 0 | 6 | 8 | 7 | |
T2 | 1 | 4 | 13 | 14 | |
T3 | 1 | 2 | 15 | 18 | |
T4 | 0 | 3 | 12 | 22 | |
Lymph node metastasis | 0.007 | ||||
N0 | 0 | 4 | 10 | 6 | |
N1 | 1 | 5 | 12 | 9 | |
N2 | 0 | 3 | 12 | 20 | |
N3 | 1 | 3 | 14 | 26 |
Expression of HNF-4α was detected using immunohistochemical staining in 126 cases of human gastric cancer tissue specimens. Association of HNF-4α with clinicopathological factors was evaluated using SPSS statistical software. HNF-4α, hepatocyte nuclear factor-4α.